The trial is taking place at:
Q

Quest Clinical Research | San Francisco, CA

Veeva-enabled site

Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101

E

Excision BioTherapeutics

Status and phase

Invitation-only
Phase 1

Conditions

HIV-1-infection

Treatments

Biological: EBT-101

Study type

Interventional

Funder types

Industry

Identifiers

NCT05143307
EBT-101-002

Details and patient eligibility

About

Participants who receive EBT-101 in a parent protocol will be eligible to participate in this long-term follow-up (LTFU) study (EBT-101-002).

Full description

Participants who receive EBT-101 in a parent protocol will be eligible to participate in this LTFU study (EBT-101-002). All participants will have follow-up visits every six months until Year 5 post EBT-101. Thereafter, all participants will have follow-up visits annually on the anniversary of EBT-101 administration until study completion at Year 15.

Enrollment

9 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Willing and able to provide written, signed informed consent
  • Participants who received the investigational study intervention EBT-101 in a parent study

Exclusion criteria

• Participants who did not receive EBT-101 in a parent study

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

9 participants in 1 patient group

Long Term Follow Up
Experimental group
Description:
Participants who received EBT-101 in a parent study will undergo long term follow up
Treatment:
Biological: EBT-101

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems